Teva Branded Pharmaceutical Products R&d Llc

This study tested a new long-acting olanzapine injection (TV-44749) against the standard oral olanzapine pill in 153 people with schizophrenia. The goal was to see if the shot delivers the same amount of medicine into the body and to check its safety. Participants received multip…

This study tested a long-acting injectable form of olanzapine (TV-44749) in 675 adults with schizophrenia. The goal was to see if a monthly shot could control symptoms better than a placebo. The trial lasted up to 61 weeks and measured changes in symptom severity using standard p…

This study looked at the long-term safety of a monthly injection called fremanezumab to prevent migraine in children aged 6 to 17. Over 500 participants were followed for up to 7 years. The goal was to see if the drug is safe and helps reduce headache days over time.

This study looked at how well different versions of the drug TEV-56286 are absorbed by the body. It involved 47 healthy adults who took single doses of the drug in different forms. The main goal was to compare the new formulations to the original capsule. The study also monitored…

This study tested three different slow-release versions of the drug olanzapine, given as a shot under the skin, in 106 adults with schizophrenia or schizoaffective disorder. The main goal was to measure how the drug enters the blood and how long it stays. Researchers also checked…